The antibacterial drugs market size was around US$54.8 billion in 2026.
Asia Pacific holds the largest share of the global antibacterial drugs market.
The main drivers of antibacterial drugs market growth include the escalating prevalence of drug-resistant bacterial infections, advancements in antibacterial drug development technologies, increasing investments in research and development, and the critical need for effective treatments amid global health challenges.
In 2023, the penicillin category held a significant share of the global market.
The hospital pharmacies segment constitutes a major share of the market.